<?xml version="1.0" encoding="UTF-8"?>
<fig id="antioxidants-09-00636-f005" orientation="portrait" position="float">
 <label>Figure 5</label>
 <caption>
  <p>(
   <bold>Left</bold>) Individuals with the longer GT repeat allele HO-1 genetic polymorphism has lower HO-1 expression and decreased endothelial hemostasis. Rapid CYP2D6 metabolizers develop subtherapeutic drug levels. (
   <bold>Right</bold>) Individuals with the shorter GT repeat allele have higher HO-1 expression and increased endothelial hemostasis. Poor CYP2D6 metabolizers develop toxic drug levels. The endothelium in all organs can be affected in larger GT allele individuals including the endothelium in the lungs, kidney, and the rest of the cardiovascular system.
  </p>
 </caption>
 <graphic xlink:href="antioxidants-09-00636-g005" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
